UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Leonard Rickey Investment Advisors P.L.L.C.

Leonard Rickey Investment Advisors P.L.L.C. increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 496 shares of the healthcare conglomerate’s stock after acquiring an additional 37 shares during the period. Leonard Rickey Investment Advisors P.L.L.C.’s holdings in UnitedHealth Group were worth $251,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Ulland Investment Advisors LLC raised its holdings in shares of UnitedHealth Group by 1.2% in the 4th quarter. Ulland Investment Advisors LLC now owns 12,485 shares of the healthcare conglomerate’s stock worth $6,316,000 after purchasing an additional 153 shares in the last quarter. Sky Investment Group LLC lifted its position in shares of UnitedHealth Group by 2.7% during the 4th quarter. Sky Investment Group LLC now owns 13,306 shares of the healthcare conglomerate’s stock valued at $6,731,000 after acquiring an additional 347 shares during the last quarter. Wealthquest Corp raised its position in shares of UnitedHealth Group by 7.8% during the fourth quarter. Wealthquest Corp now owns 470 shares of the healthcare conglomerate’s stock worth $238,000 after purchasing an additional 34 shares during the period. Amplius Wealth Advisors LLC boosted its position in shares of UnitedHealth Group by 11.8% in the 4th quarter. Amplius Wealth Advisors LLC now owns 1,093 shares of the healthcare conglomerate’s stock valued at $553,000 after purchasing an additional 115 shares during the period. Finally, Gemmer Asset Management LLC raised its holdings in UnitedHealth Group by 5.7% during the 4th quarter. Gemmer Asset Management LLC now owns 742 shares of the healthcare conglomerate’s stock worth $375,000 after buying an additional 40 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $510.03 on Tuesday. The firm has a market capitalization of $469.37 billion, a PE ratio of 32.91, a PEG ratio of 1.39 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm’s fifty day simple moving average is $549.37 and its 200 day simple moving average is $563.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.83 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.77 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio is 54.19%.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on UNH shares. UBS Group cut their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Bank of America decreased their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday. Royal Bank of Canada dropped their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Finally, Piper Sandler lowered their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Two equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.